Programmed cell death ligand 1 (PD-L1) blockade attenuates metastatic colon cancer growth in cAMP-response element-binding protein (CREB)-binding protein (CBP)/β-catenin inhibitor-treated livers

Immune checkpoint blockade with specific antibodies can accelerate anti-tumor immunity, resulting in clinical responses in patients with various types of cancer. However, these antibodies achieve only partial tumor regression. Thus, a wide variety of treatment combinations based on programmed death-...

Descripción completa

Detalles Bibliográficos
Autores principales: Osawa, Yosuke, Kojika, Ekumi, Nishikawa, Koji, Kimura, Masamichi, Osakaya, Shigenori, Miyauchi, Hiromi, Kanto, Tatsuya, Kawakami, Yutaka, Kimura, Kiminori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508964/
https://www.ncbi.nlm.nih.gov/pubmed/31105882
http://dx.doi.org/10.18632/oncotarget.26892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508964/
https://www.ncbi.nlm.nih.gov/pubmed/31105882
http://dx.doi.org/10.18632/oncotarget.26892

Ejemplares similares